Citation: Sp. Reddy et al., Parotid-sparing irradiation for cancer of the oral cavity - Maintenance oforal nutrition and body weight by preserving parotid function, AM J CL ONC, 24(4), 2001, pp. 341-346
Authors:
Reddy, SP
Narayana, A
Melian, E
Kathuria, S
Leman, C
Emami, B
Citation: Sp. Reddy et al., Stomal recurrence in patients with T1 glottic cancer after salvage laryngectomy for radiotherapy failures - Role of p53 overexpression and subglotticextension, AM J CL ONC, 24(2), 2001, pp. 124-127
Authors:
Clark, JI
Hofmeister, C
Choudhury, A
Matz, G
Collins, S
Bastian, R
Melian, E
Emami, B
Petruzzelli, G
Citation: Ji. Clark et al., Phase II evaluation of paclitaxel in combination with carboplatin in advanced head and neck carcinoma, CANCER, 92(9), 2001, pp. 2334-2340
Citation: Mw. Lingen et al., New therapeutic strategies for the treatment and prevention of head and neck cancer, EXPERT OP I, 9(12), 2000, pp. 2855-2872
Authors:
Krasin, M
McCall, A
King, S
Olson, M
Emami, B
Citation: M. Krasin et al., Evaluation of a standard breast tangent technique: A dose-volume analysis of tangential irradiation using three dimensional tools, INT J RAD O, 47(2), 2000, pp. 327-333
Authors:
Dogan, N
Leybovich, LB
Sethi, A
Krasin, M
Emami, B
Citation: N. Dogan et al., A modified method of planning and delivery for dynamic multileaf collimator intensity-modulated radiation therapy, INT J RAD O, 47(1), 2000, pp. 241-245
Citation: Gj. Petruzzelli et B. Emami, Nonsurgical treatment of advanced metastatic cervical disease in cancer ofthe larynx, ORL-J OTO R, 62(4), 2000, pp. 226-233
Authors:
Leybovich, LB
Dogan, N
Sethi, A
Krasin, MJ
Emami, B
Citation: Lb. Leybovich et al., Improvement of tomographic intensity modulated radiotherapy dose distributions using periodic shifting of arc abutment regions, MED PHYS, 27(7), 2000, pp. 1610-1616
Authors:
Sause, W
Kolesar, P
Taylor, S
Johnson, D
Livingston, R
Komaki, R
Emami, B
Curran, W
Byhardt, R
Dar, AR
Turrisi, A
Citation: W. Sause et al., Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer - Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group, CHEST, 117(2), 2000, pp. 358-364
Authors:
Graham, MV
Purdy, JA
Emami, B
Harms, W
Bosch, W
Lockett, MA
Perez, CA
Citation: Mv. Graham et al., Clinical dose-volume histogram analysis for pneumonitis after 3D treatmentfor non-small cell lung cancer (NSCLC), INT J RAD O, 45(2), 1999, pp. 323-329
Authors:
Cox, JD
Scott, CB
Byhardt, RW
Emami, B
Russell, AH
Fu, KK
Parliament, MB
Komaki, R
Gaspar, LEW
Citation: Jd. Cox et al., Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): Analysis of radiation therapy oncology group (RTOG) trials, INT J RAD O, 43(3), 1999, pp. 505-509
Citation: B. Emami, Optimization of volume in radiotherapy of non-small cell lung cancer: small volume, TREATMENT OPTIMIZATION FOR LUNG CANCER, 1998, pp. 59-65
Authors:
Cox, JD
Scott, CB
Smith, C
Phillips, TL
Emami, B
Byhardt, RW
Slater, JM
Asbell, SO
Hartsell, WF
Citation: Jd. Cox et al., Dose escalation for non-small cell carcinoma of the lung before 3D conformal radiation therapy: long-term observations of normal tissues from RTOG protocol 83-11, TREATMENT OPTIMIZATION FOR LUNG CANCER, 1998, pp. 151-156